-- プロクター・アンド・ギャンブル(PG)は金曜日、予想を上回る好調な第3四半期決算を発表し、通期業績見通しを据え置いた。 クレスト歯磨き粉やパンパースおむつなどを製造する同社は、3月期第3四半期の調整後1株当たり利益が1.59ドルとなり、前年同期の1.54ドルから増加、ファクトセットのコンセンサス予想である1.56ドルを上回った。売上高は7%増の212億4000万ドルとなり、市場予想の205億3000万ドルを上回った。 株価は直近のプレマーケット取引で3%上昇した。 シャイレシュ・ジェジュリカー最高経営責任者(CEO)は声明で、「第3四半期は、製品カテゴリーと地域を問わず幅広い成長を遂げ、売上高が力強く加速した」と述べた。「厳しい地政学的・経済的環境にもかかわらず、消費者の勢いを加速させるために投資を増やしており、通期業績見通しは維持している」と付け加えた。 プロクター・アンド・ギャンブル(P&G)は、2026年度の調整後1株当たり利益(EPS)を6.83ドルから7.09ドルの範囲と引き続き予測しており、市場予想の6.93ドルを上回っています。また、通期売上高成長率のガイダンスを1%から5%、オーガニック売上高の見通しを前年比4%増と据え置いています。 純ベースでは、2026年度の1株当たり利益は引き続き1%から6%の成長を見込んでいます。 P&Gは第3四半期に株価が全体で1%上昇し、販売数量は2%増加しました。為替変動の影響で売上高は4%増加しました。為替変動の影響を除いたオーガニックベースでは、売上高は3%増加し、販売数量は2%増加しました。 ファブリック&ホームケア、グルーミング、ヘルスケアの各セグメントの売上高は、いずれも前年同期比で7%増加しました。ビューティー部門の売上高は11%増の38億7000万ドル、ベビー・フェミニンケア・ファミリーケア部門の売上高は6%増の50億6000万ドルを記録しました。 同社によると、コア粗利益率は前年同期比で100ベーシスポイント低下しました。これは、製品構成の悪化、再投資、関税によるコスト増などが要因となっています。 ジェジュリカー氏は、「持続可能でバランスの取れた成長への最善の道は、統合的な成長戦略の実行を強化することだと引き続き確信しています。当社はこれまでの進捗状況に自信を持っており、長期的な機会に大きな期待を寄せています」と述べています。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.